Cytology
diagnoses according to the National Nomenclature per sample in year 2021
Reflex cytology (Screening HPV) |
Indicated cytology |
|||||||||||||
Screening
cytology (Reflex HPV) |
||||||||||||||
SNOMED |
Number |
Percent |
Number |
Percent |
Number |
Percent |
||||||||
Not assessable |
M09010 |
816 |
0.86% |
227 |
1.10% |
2 932 |
2.76% |
|||||||
Missing endocervical cells |
M09019 |
5 583 |
5.89% |
1 387 |
6.71% |
8 957 |
8.42% |
|||||||
Normal/ benign samples |
M00110 |
66
447 |
70.1% |
10
761 |
52.1% |
79
315 |
74.6% |
|||||||
Atypical squamous cells of unknown origin (ASC-US) |
M69710 |
6 517 |
6.88% |
4 976 |
24.1% |
12
152 |
11.4% |
|||||||
Suspected high-grade dysplasia (ASC-H) |
M69719 |
444 |
0.47% |
529 |
2.56% |
1 606 |
1.51% |
|||||||
low-grade squamous intraepithelial lesions (ASC-US) |
3 614 |
3.81% |
2 450 |
11.9% |
8 964 |
8.43% |
||||||||
High-grade squamous intraepithelial lesions / HSIL |
729 |
0.77% |
900 |
4.35% |
2 379 |
2.24% |
||||||||
Suspicion of squamous cancer |
1 |
0.00% |
5 |
0.02% |
60 |
0.06% |
||||||||
Atypical glandular cells (AGC) |
M69720 |
59 |
0.06% |
183 |
0.89% |
602 |
0,57% |
|||||||
Adenocarcinoma in situ (AIS) or suspicion of Adenocarcinoma |
5 |
0.01% |
36 |
0.17% |
145 |
0.14% |
||||||||
Atypia in cells of unclear/ other cell type |
M69700 |
|
0.00% |
|
000% |
|
0.00% |
|||||||
Malignant cells of unclear cell type/ other cell type |
M80009 |
31 |
0.03% |
47 |
0.23% |
152 |
0.14% |
|||||||
Non-interpretable |
0 |
000% |
1 |
0.00% |
26 |
0.02% |
||||||||
Number of samples |
|
94 774 |
|
20
669 |
|
106
376 |
|
|||||||
1 M74006 (CIN1) was assigned to M80770 (LSIL) ;
2 M74007 (CIN2) och M80702 (CIN3)
was assigned to M80772
(HSIL);
3 M80703 was assigned to M80701
(suspicion about squamous cell carcinoma)); 4 M81403 (Adenocarcinoma) was
assigned to M81401 (suspicion about Adenocarcinoma)